| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |